What's in Chiesi Farmaceutici's pipeline?

Chiesi Farmaceutici has 4 drugs in our index: 4 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Chiesi Farmaceutici's portfolio?

Top competitors by shared drug class: AstraZeneca, , Azurity, Novartis, Pfizer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/chiesi.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

Chiesi Farmaceutici — Portfolio Competitive Intelligence Brief

Chiesi Farmaceutici pipeline: 4 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Kengreal	CANGRELOR	marketed	P2Y12 Platelet Inhibitor [EPC]	P2Y purinoceptor 12	Metabolic	2015-01-01
Juxtapid	LOMITAPIDE	marketed	Microsomal Triglyceride Transfer Protein Inhibitor	Microsomal triglyceride transfer protein large subunit	Metabolic	2012-01-01
Ferriprox	DEFERIPRONE	marketed	Iron Chelator [EPC]	Deoxyhypusine hydroxylase	Other	2011-01-01
Cleviprex	CLEVIDIPINE	marketed	Dihydropyridine Calcium Channel Blocker [EPC]	Voltage-dependent L-type calcium channel subunit alpha-1C	Cardiovascular	2008-01-01

Therapeutic area mix

Metabolic · 2
Cardiovascular · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 2 shared drug classes
· 1 shared drug class
Azurity · 1 shared drug class
Novartis · 1 shared drug class
Pfizer · 1 shared drug class
Smithkline Beecham · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Chiesi Farmaceutici:

Cite this brief

Drug Landscape (2026). Chiesi Farmaceutici — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/chiesi. Accessed 2026-05-14.